A phase I/II study of adenovirus-mediated interleukin-12 gene therapy for hormone refractory prostate cancer: An interim report

Category Primary study
JournalJournal of Clinical Oncology
Year 2011
This article has no abstract
Epistemonikos ID: fa6f6d64ce635f712d8b4dfde1e8015705cb25f3
First added on: Feb 04, 2025